Klee Irwin Presenting at Psychedelic Capital
May 25, 2022 11:49 ET
|
Irwin Naturals
LOS ANGELES, May 25, 2022 (GLOBE NEWSWIRE) -- Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) announced today that Klee Irwin, CEO, will be presenting at the...
Mydecine Announces MYCO-005 Family of Improved Safety Microdose Novel Molecules
February 16, 2022 07:30 ET
|
Mydecine Innovations Group Inc.
DENVER, Feb. 16, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), a biotechnology company aiming to transform the...
PSYC Establishes New Partnership with Industry Leader, Microdose Psychedelic Insights
August 18, 2020 08:30 ET
|
Global Trac Solutions, Inc.
LAS VEGAS, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that in an effort to accelerate the Company’s...
PSYC Interviews Chief Architects and Petitioners of Oregon’s Psilocybin Therapy Initiative
July 21, 2020 08:30 ET
|
Global Trac Solutions, Inc.
LAS VEGAS, July 21, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce the release of a special edition of its Microdose...
PSYC Expands its Reach with the Launch of Social Media Platforms
July 16, 2020 08:30 ET
|
Global Trac Solutions, Inc.
LAS VEGAS, July 16, 2020 (GLOBE NEWSWIRE) -- Global Trac Solutions, Inc. (OTCPink: PSYC) (“Global” “PSYC” or the “Company”) is pleased to announce that the Company’s new social media channels are...
PLUS™ Unveils New Classic Mints
April 18, 2019 07:30 ET
|
Plus Products Inc.
SAN MATEO, Calif., April 18, 2019 (GLOBE NEWSWIRE) -- Continuing to demonstrate its passion for providing low-dose cannabis edibles that consumers love, Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF)...
Eyenovia, Inc. announces publication of Phase II study results demonstrating benefits of micro-formulation over conventional eyedroppers and addition of Scientific Advisory Board members
November 28, 2016 15:46 ET
|
Eyenovia, Inc
Eyenovia’s study shows that conventional ophthalmic eye drops significantly overdose the eye and that equivalent, or greater, pharmacodynamic effect can be achieved with 80% less ocular exposure...